bioAffinity Technologies (BIAF) Assets Average (2022 - 2026)

bioAffinity Technologies (BIAF) has 5 years of Assets Average data on file, last reported at $9.5 million in Q1 2026.

• Assets Average for Q1 2026 came in at $9.5 million, up 56.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.5 million (up 56.75% YoY), and the FY2025 annual result was $8.7 million, up 18.59% from the prior year.
• Assets Average retreated to $9.5 million in Q1 2026 per BIAF's latest filing, from $11.3 million in the prior quarter.
• Over five years, Assets Average peaked at $13.1 million in Q4 2022 and troughed at $5.1 million in Q2 2025.
• A 5-year average of $8.7 million and a median of $8.7 million in 2023 frame the typical range for Assets Average.
• The sharpest annual moves came in 2024 and 2025: Assets Average tumbled 30.71% in 2024, then jumped 72.26% in 2025.
• A 5-year view of Assets Average shows it stood at $13.1 million in 2022, then dropped by 29.85% to $9.2 million in 2023, then slipped by 29.03% to $6.5 million in 2024, then soared by 72.26% to $11.3 million in 2025, then dropped by 16.0% to $9.5 million in 2026.
• Business Quant data shows BIAF's Assets Average at $9.5 million in Q1 2026, $11.3 million in Q4 2025, and $8.1 million in Q3 2025.